Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

GeoVax begins new study of HIV vaccine

Jan. 24, 2017

Full phase I data reported for novel anti-HIV compound ABX-464

Jan. 20, 2017

NIAID initiates phase I trial of VRC07-523LS

Jan. 19, 2017

GlaxoSmithKline describes new indoleamine 2,3-dioxygenase 1 inhibitors

Jan. 18, 2017

Kyorin Pharmaceutical prepares and tests FPR2 agonists

Dec. 19, 2016

Merck & Co. describes HIV integrase inhibitors

Dec. 16, 2016

Novel HIV-1-specific bNAb can achieves near pan-neutralization of HIV-1

Dec. 14, 2016

New phase I trial explores use of PGT-121 for HIV prevention and therapy

Dec. 12, 2016

Abivax provides update on clinical development program for ABX-464

Dec. 9, 2016

HVTN initiates phase IIb/III trial of investigational HIV vaccine regimen in South Africa

Nov. 28, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...